scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1005467155 |
P356 | DOI | 10.1186/S12885-016-2692-4 |
P3181 | OpenCitations bibliographic resource ID | 3973892 |
P932 | PMC publication ID | 4992258 |
P698 | PubMed publication ID | 27542890 |
P50 | author | Manolis Kogevinas | Q28320569 |
Marcela Guevara | Q39700348 | ||
Beatriz Pérez-Gómez | Q40005362 | ||
Víctor Moreno | Q40183186 | ||
Rafael Marcos-Gragera | Q43480009 | ||
Pilar Amiano | Q43521651 | ||
Virginia Lope | Q45668600 | ||
Aurelio Barricarte | Q46161972 | ||
Ines Gomez-Acebo | Q50434947 | ||
Marina Pollan | Q51579203 | ||
Nuria Aragonés | Q51631857 | ||
Gemma Castaño-Vinyals | Q52657955 | ||
Adonina Tardón | Q55454742 | ||
Esther Gracia-Lavedan | Q63790051 | ||
M Henar Alonso | Q90228046 | ||
Trinidad Dierssen-Sotos | Q91870814 | ||
Rosana Peiro-Perez | Q114441113 | ||
Maria Jesus Michelena-Echeveste | Q114441114 | ||
Marian Diaz-Santos | Q114735280 | ||
P2093 | author name string | Javier Llorca | |
Sonia Servitja | |||
Tania Fernandez-Villa | |||
María de Pedro | |||
Andrés Garcia-Palomo | |||
P2860 | cites work | Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis | Q24646764 |
Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors | Q25257303 | ||
Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer | Q25257496 | ||
Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative | Q28165551 | ||
Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status | Q28176257 | ||
Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case-Control Surveillance Study revisited | Q28181502 | ||
Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer | Q28194496 | ||
Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study | Q28196301 | ||
Association of regular aspirin use and breast cancer risk | Q28211831 | ||
Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort | Q28213690 | ||
Nonsteroidal antiinflammatory drug use and breast cancer risk: subgroup findings | Q28218969 | ||
NSAID use and breast cancer risk in the VITAL cohort | Q28219138 | ||
Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort | Q28219482 | ||
Cyclooxygenase-2 and the inflammogenesis of breast cancer. | Q30367680 | ||
The role of cyclooxygenases in inflammation, cancer, and development | Q33814331 | ||
Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study | Q33889458 | ||
Cyclooxygenase-2: a target for the prevention and treatment of breast cancer | Q34277077 | ||
Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis. | Q34458235 | ||
Role of COX-independent targets of NSAIDs and related compounds in cancer prevention and treatment | Q35148973 | ||
Exposure to cyclooxygenase-2 inhibitors and risk of cancer: nested case-control studies | Q35212665 | ||
Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. | Q36234570 | ||
Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors | Q36498885 | ||
Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage | Q36641796 | ||
Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study | Q36678729 | ||
Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database | Q37340253 | ||
Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer | Q38490106 | ||
Medication use and the risk of breast cancer | Q39796441 | ||
Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells | Q40228364 | ||
Nonsteroidal Anti-inflammatory Drugs and Cancer | Q40435556 | ||
Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast | Q40534891 | ||
Nonsteroidal antiinflammatory drugs and breast cancer | Q44378169 | ||
Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study | Q46743593 | ||
Nonsteroidal anti-inflammatory drug use is associated with cancer risk reduction in chronic dialysis patients | Q48499081 | ||
Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer. | Q50636879 | ||
Population-based multicase-control study in common tumors in Spain (MCC-Spain): rationale and study design. | Q50970275 | ||
Protective effect of NSAIDs on cancer and influence of COX-2 C(-765G) genotype. | Q53315047 | ||
The Relationship of Nonsteroidal Anti-inflammatory Drug Use to the Risk of Breast Cancer | Q59763658 | ||
Breast Cancer and NSAID Use: Heterogeneity of Effect in a Case-Control Study | Q71836037 | ||
Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor | Q73726017 | ||
Nonsteroidal anti-inflammatory drug use and breast cancer risk | Q77144771 | ||
Nonsteroidal anti-inflammatory drugs and the risk of developing breast cancer in a population-based prospective cohort study in Washington County, MD | Q79852024 | ||
Epidemiologic-study of nonsteroidal antiinflammatory drugs and breast-cancer | Q84152319 | ||
Selective cyclooxygenase-2 (COX-2) inhibitors and breast cancer risk | Q84773247 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 660 | |
P577 | publication date | 2016-08-20 | |
P1433 | published in | BMC Cancer | Q326300 |
P1476 | title | Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study | |
P478 | volume | 16 |